We found 85 records for "Purchasing / procurement"

Articles

The new Cancer Drugs Fund: sticking plaster 2.0 or a model for the future?

12th February 2016

 The new Cancer Drugs Fund: sticking plaster 2.0 or a model for the future?Articles

A new, value-based Cancer Drugs Fund is set to be launched in England soon, but pharma companies fear it will be a step backwards for access to new cancer medicines. Andrew...

Read more

Taking the ‘burden’ out of caregiver burden

1st February 2016

 Taking the ‘burden’ out of caregiver burdenArticles

Ageing populations and rising numbers of people with chronic conditions mean more and more people are becoming informal caregivers. When new treatments are developed, regulators should take into account the...

Read more

The ‘new’ economics of drug pricing

8th January 2016

 The ‘new’ economics of drug pricingArticles

Leela Barham considers the impact of the many influences on medicines pricing today, ranging from government regulation to patient-group pressure.Prices of medicines always seem to be controversial. The economics underlying...

Read more

Access to new medicines in Scotland

23rd December 2015

 Access to new medicines in Scotland Articles

Leela Barham considers the history of Scottish Medicines Consortium (SMC) drug approvals in Scotland and whether the trend is towards greater access in recent years.The Scottish Parliamentary Health and Sport...

Read more

News

Innovative medicines and a healthy late-stage pipeline will drive US drug spending to $640bn by 2020

19th April 2016

 Innovative medicines and a healthy late-stage pipeline will drive US drug spending to $640bn by 2020News

Annual prescription drug spending in the US could hit $640 billion by 2020 despite an overall slowdown in year-on-year growth, according to a new report.The figure, which does not consider...

Read more

Novartis faces fresh bribery claims in Turkey

31st March 2016

 Novartis faces fresh bribery claims in TurkeyNews

Novartis faces bribery claims in relation to drug prescriptions following reports from an anonymous Turkish whistleblower.The claims relate to allegations that Novartis funnelled bribes to hospitals via Turkish consultancy firm...

Read more

CF drug Kalydeco took up 86% of Scotland's rare disease fund

29th March 2016

 CF drug Kalydeco took up 86% of Scotland's rare disease fundNews

Spending on Vertex's cystic fibrosis drug Kalydeco accounted for the vast majority of Scotland's Rare Conditions Medicines Fund (RCMF) last year.An investigation by the Scotland's Sunday Herald newspaper found that...

Read more

Pfizer and Allergan set to announce $150 billion merger

23rd November 2015

 Pfizer and Allergan set to announce $150 billion mergerNews

Pfizer is on the brink of confirming a merger with Allergan worth $150 billion, creating the world's biggest pharma company.The mega-merger would be the biggest ever pharma acquisition, topping of...

Read more

White Papers

Pricing & Market Access Outlook 2015/2016 Edition

11th November 2015

 Pricing & Market Access Outlook 2015/2016 EditionWhite Papers

Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet...

Read more

Pricing & Market Access Outlook 2014

20th October 2014

 Pricing & Market Access Outlook 2014White Papers

Pricing and market access are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need,...

Read more

Press Releases

The World's Largest Healthcare Event - tHIS Opens to Record Breaking Crowds

19th June 2015

The World's Largest Healthcare Event - tHIS Opens to Record Breaking Crowds

SHANGHAI, May 19, 2015 -- The 2015 Health Industry Summit (tHIS), an event that was predicted to transform the Chinese healthcare industry sector, opened to huge crowds on May 15,...

Read more

New recruit at Cognite

21st May 2015

New recruit at Cognite

Cognite is pleased to announce that Arun Dhillon has joined the company as an Account Director. Arun was previously with ICC Lowe (formerly Brand(x)) working out of the Zurich office...

Read more

Zephyr Health Joins Veeva OpenKey Partner Program

25th March 2015

Zephyr Health Joins Veeva OpenKey Partner Program

Zephyr Health aligns with Veeva on new approach to customer data that’s open and easy San Francisco — March 24, 2015 – Zephyr Health, the only Data Intelligence solution built specifically for health science...

Read more

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more